PDA Capital Area Chapter
Chapter's Region:
Washington, DC / Maryland / Virginia (Northern) / West Virginia
Welcome to the PDA Capital Area chapter website. Here you will find information regarding all chapter activities. We encourage you to stay connected to your local industry community by participating in an upcoming chapter event or forum discussion. Chapter Leaders welcome your questions/comments and look forward to hearing from you.
Chapter Events
Sponsors
PDA Capital Area Chapter welcomes sponsors to participate in upcoming events. We thank all the sponsors who have supported PDA Capital Area events in the past.
Please send all sponsorship inquires to Martin Jenkins, Chapter President.
2024 Event Calendar
2024 Sponsorship Opportunities Book Your Sponsorship Today
About Us
The PDA Capital Area Chapter has its origins dating back to the fall of 1992. It all started with a phone to PDA President Edmund Fry from Rande Leibowitz, who had just moved to Maryland from New England, where he was active in the New England Chapter. When he was informed that no local PDA chapter existed, he asked the simple question, "why not?" Soon Rande found himself with a list of local PDA members and a mission: form the chapter.
Rande got together with a core group of dedicated volunteers and started work on the chapter's first activity: a questionnaire to gauge local interest. Soon we organized our first meeting. In the spring of 1994, Rande Leibowitz was elected first Chapter President, along with Bill Stoedter, Kelly Langan and Sylvia Issacson as President-Elect, Secretary and Treasurer, respectively.
We have been holding three to four meetings a year, consisting of both conventional dinner meetings and site tours of local facilities. We have heard excellent presentations by various speakers including our very first meeting in 1993, where Mike Beatrice (then at FDA) spoke about multi-use facilities and changes in FDA.
There are many people and companies to thank for the success of the Capital Area Chapter. Without them, we wouldn't be able to serve the Washington, D.C. Metro area PDA members with fine local programs and events. Thanks to all and keep up your support!
Members At Large
- Dina El-Emary, MEng., MBA
- Krystian Gonzalez-Vasques, CQV Engineer II, Integrated Project Services, LLC
- Ben Bhattarai, Medical Assistant/Coordinator, Bowie Town Behavioural Services
- Stephanie Brandford, Validation Consultant, Brayearst Validation Consulting
- Janie Miller, Director, External Affairs, Amgen
Past Presidents
- Tita Tavares, Immediate Past President and Chapter Advisor
- Allen L. Burgenson, 2005 - 2009
- Barry A. Friedman, Ph.D. 2004 - 2005
- Robert J. Mello, Ph.D. 2002 - 2004
- Allen L. Burgenson, 1999 - 2002
- William H. Stoedter, 1997- 1999
- Randy Liebowitz, 1995 - 1997
Get Involved
We welcome the active participation of PDA members as well as non-members as we chart our course for the future. If you would like more information about ways to get involved with the PDA Capital Area Chapter, please contact Martin Jenkins, Chapter President, martinjenkinspmp@comcast.net.
Capital Area Chapter is looking for volunteers for the following committees:
- Membership Committee
- Publications Committee
- Vendor Show Committee
- Meetings Committee
- Special Events Committee
Recorded Presentation
Webinar: PDA Final Take- By Sharif Tusuubira
Event Date: January 26, 2023
Webinar:Remote Compliance Auditing During the COVID-19 Pandemic
Event Date: July 28, 2020
Webinar: Designing Flexibility into the Full Temperature Range of GMP BioPharma Storage
Event Date: June 26, 2020
Chapter Officers
-
Martin Jenkins
President/Senior Consultant
President
Circle MJ Consulting
Martin Jenkins, PMP has over 25 years of experience leading equipment and facility qualifications, technology development and transfers, as well as leading projects and programs in the pharmaceutical, biotechnology, and life science industries. He is currently the Senior Project Manager for Qualification and Validation at Circle MJ Consulting. Martin is also the President of the Capital Area Chapter of the PDA. Martin’s experiences include working with CGMP products such as API drugs, bulk pharmaceuticals, medical devices, sterile injectables, customized cell culture products, enzymes, amino acids, proteins, chemicals, animal health and agricultural products in the areas of analytical chemistry, molecular biology, microbiology, forensics, veterinary, and entomology. This includes processes such as drug and device manufacturing, cleaning, environmental monitoring, spray drying, packaging, utility qualification, facility commissioning, labelling, product design, laboratory and assay testing.
Martin is well versed in Validation, Quality Initiatives, Quality Assurance and Regulatory Affairs, R&D, Process Analytical Technology, Manufacturing Operations, Commissioning, Remediation, ALCOA+ Documentation Principles, Program Leadership, Project Management, Team Development, Design for Six Sigma, CGDP, Risk Assessment, DMAIC Six Sigma, Lean, Process Analysis, and Lab Management. He is skilled also in leading multi-site level projects with small and large teams.
-
Sapan Patel
Associate Director, Quality Assurance
Treasurer
AstraZeneca
Sapan Patel is a seasoned quality assurance leader with extensive expertise in the pharmaceutical and biopharmaceutical sectors, currently positioned as Associate Director QA at AstraZeneca. Fluent in multiple languages including Hindi, Gujarati, English, and Spanish, he brings a multicultural and inclusive perspective to his leadership roles. Based in Gaithersburg, Maryland, Sapan has demonstrated a robust ability to lead quality initiatives across various operational and strategic levels.
Holding a Master of Science in Pharmaceutical Manufacturing from Stevens Institute of Technology and a Bachelor of Science in Pharmacy from Rajiv Gandhi University of Health Sciences, Sapan has developed a solid foundation in drug development and manufacturing. His career includes significant stints at MilliporeSigma and MedImmune, where he led numerous quality improvement projects, demonstrating his capabilities in cross-functional team leadership and regulatory compliance.
Sapan's professional skills are vast, encompassing regulatory affairs, process validation, cleaning validation, and a proficiency in using Minitab for statistical analysis. His core areas of expertise include talent development, process transfer, scale-up initiatives, and process improvement, with a strong emphasis on employing Quality Risk Management (QRM) to make informed, risk-based decisions.
At AstraZeneca, Sapan has been instrumental in enhancing product quality leadership, focusing on strategic quality decision-making and improvement. His leadership extends to teaching and mentoring, preparing the next generation of quality professionals for future challenges in the industry.
-
Julie Barnhill
Senior Consultant
Secretary
Meridian BioGroup
Julie Barnhill is a dynamic and results-driven professional based in Baltimore, Maryland, currently serving as a Senior Consultant with Meridian BioGroup - Pace® Life Sciences. With over 20 years of experience in the biopharmaceutical sector, she excels in designing, implementing, and managing compliance and quality systems. Her expertise is deeply rooted in FDA and DEA regulatory standards, having successfully managed numerous regulatory inspections.Dr. Barnhill's journey in the biotechnology field is fortified by an extensive educational background, holding a PhD in Biochemistry from the University of Pennsylvania, complemented by a Bachelor of Science in Chemistry from Trinity College-Hartford. Her academic prowess led her to teach in the graduate Biotechnology program at Johns Hopkins University, sharing her knowledge and experience with aspiring professionals.Previously, Julie held significant roles at Osiris Therapeutics as Senior Manager of Quality Systems and at Actavis (formerly Alpharma Pharmaceuticals) as a QA Compliance Manager. Her career also includes a tenure at Charles River Laboratories as Senior Manager of Process Development and at Chesapeake Biological Labs as Director of Quality Control. In these positions, she led critical initiatives ranging from process development for clinical phase biologics to overseeing quality control for both clinical and commercial products.Julie's specialties encompass a broad spectrum, including cGMP, GTP, GCP, GLP, FDA compliance, quality systems, and quality auditing. At Meridian BioGroup, she continues to leverage her skills in auditing and consulting to enhance client engagements and ensure stringent compliance with global regulatory authorities.
Presentations & Resources
- PDA Chapter Council Presentation 11 April 2024
- Minimizing risk in your raw material supply chain
- Process Validation FDAs 2011 Guidance
- Dispelling the Myths of Cleaning Validation
- Combination Products A Regulatory Perspective
- A Response to FDA Perspective on Approaches for Complying with CGMPS During Phase I INDs Draft Guidance for Industry
- Aseptic Processing Risk Assessment The Simplified Akers-Agalloco Method
- Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives
- Remote Compliance Auditing During the COVID-19 Pandemic
- FDA Perspective on Approaches for Complying with CGMPS During Phase I INDs Draft Guidance for Industry
- Risk Assessment Principles for the Product Quality Initiatives
- Its a Bird It’s a Plane No Wait It is Finally Multi-Center Current Thinking on Parametric Release of Drug Products Terminally Sterilized by Moist Heat
Chapter Resources
Discover essential materials such as the chapter handbook, templates, presentations, and insightful videos tailored for new chapter leaders and the GPS network.
Access Resources